|
|
Revaluation of traditional Chinese medicine in the treatment of peptic ulcer by meta-analysis |
LI Liqun1 LIU Hongwu1 GONG Xiaokun1 CHEN Guangwen2 SONG Qingzeng1 TAN Jinjing2 XIE Sheng2 |
1.Graduate School, Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530001, China;
2.Department of Spleen and Stomach, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530001, China |
|
|
Abstract Objective To comprehensively summarize the meta-analysis on peptic ulcer treated with traditional Chinese medicine (TCM), and to evaluate the methodological quality of meta-analysis and evidence quality of outcomes. Methods Eight databases including CNKI, Wanfang, VIP, OVID, CBM, PubMed, Embase, Cochrane Library were searched to collect the published meta-analysis on peptic ulcer treated with TCM. The time was from the inception to March 2019. Two researchers conducted literature screening and data extraction independently. The methodological quality of meta-analysis was assessed by using AMSTAR2 tool. The evidence quality was evaluated by using GRADE system. Results Finally, 11 meta-analysis were included, including 38 outcomes. The results of AMSTAR showed that 2 meta-analysis had moderate methodological quality, 3 had low quality, and 6 had very low quality. Results of GRADE showed that 21 outcomes were low quality evidence, 14 outcomes were very low quality evidence, and only 3 outcomes were moderate quality evidence. Conclusion The overall methodological quality of meta-analysis on peptic ulcer treated with TCM is low, and the evidence quality of outcome is generally low, indicating low reliable results. High quality meta-analysis should be conducted in the future for further verification.
|
|
|
|
|
[1] Satoh K,Yoshino J,Akamatsu T,et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015 [J]. J Gastroenterol,2016,51(3):177-194.
[2] Sayehmiri K,Abangah G,Kalvandi G,et al. Prevalence of peptic ulcer in Iran:systematic review and Meta-analysis methods [J]. J Res Med Sci,2018,23:8.
[3] Budimir I,Stojsavljevi S,Hrabar D,et al. Bleeding peptic ulcer-tertiary center experience:epidemiology,treatment and prognosis [J]. Acta Clin Croat,2017,56(4):707-714.
[4] Malmi H,Kautiainen H,Virta LJ,et al. Increased short-and long-term mortality in 8146 hospitalised peptic ulcer patients [J]. Aliment Pharmacol Ther,2016,44(3):234-245.
[5] 李慧,陈耀龙,谢秀丽,等.中医(中西医结合)临床实践指南制修订方法——证据质量分级[J].中华中医药杂志,2016,31(7):2652-2656.
[6] Aromataris E,Fernandez R,Godfrey CM,et al. Summarizing systematic reviews:methodological development,conduct and reporting of an umbrella review approach [J]. Int J Evid Based Healthc,2015,13(3):132-140.
[7] Shea BJ,Reeves BC,Wells G,et al. AMSTAR 2:a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions,or both [J]. BMJ,2017,358:j4008.
[8] Guyatt G,Oxman AD,Akl EA,et al. GRADE guidelines:1. Introduction—GRADE evidence profiles and summary of findings tables [J]. J Clin Epidemiol,2011,64(4):383-394.
[9] Yoshida M,Kinoshita Y,Watanabe M,et al. JSGE clinical practice guidelines 2014:standards,methods,and process of developing the guidelines [J]. J Gastroenterol,2015,50(1):4-10.
[10] 徐伟茹.Hp相关性消化性溃疡中医药治疗系统评价[D].沈阳:辽宁中医药大学,2015.
[11] 刘余,龚后武,谭达全,等.半夏泻心汤加减治疗消化性溃疡的Meta分析[J].中华中医药杂志,2016,31(8):3263-3266.
[12] 邓天好,谭达全,龙承星,等.半夏泻心汤治疗幽门螺杆菌相关性胃炎与消化性溃疡的Meta分析[J].湖南中医杂志,2015,31(10):134-136,139.
[13] 魏乙锋,高岑,宋俊生.黄芪建中汤治疗消化性溃疡随机对照试验的Meta分析[J].中国中医急症,2017,26(4):572-576,615.
[14] 李子木,高海滨,姜枫.小建中汤治疗消化性溃疡的Meta分析[J].山西中医学院学报,2017,18(5):6-8.
[15] 朱晶晶.中医疗法治疗消化性溃疡的Meta分析[J].河北中医,2018,40(2):297-300.
[16] 高爽.中药汤剂治疗幽门螺杆菌相关性消化性溃疡随机对照试验的系统评价[D].沈阳:辽宁中医药大学,2013.
[17] 石绍顺.消化性溃疡的中医证治规律研究及临床疗效的系统评价[D].沈阳:辽宁中医药大学,2011.
[18] 田瑶,闫亚南,关翰宇,等.针刺治疗消化性溃疡疗效的系统评价和Meta分析[J].针刺研究,2017,42(3):275-282.
[19] 邱建利,邵明义,魏明,等.中医药治疗胃溃疡随机对照试验的系统评价[J].新中医,2011,43(5):122-124.
[20] Sun Y,Zhang J,Chen Y. Efficacy and safety of Jianzhong decoction in treating peptic ulcers:a Meta-analysis of 58 randomised controlled trials with 5192 patients [J]. BMC Complement Altern Med,2017,17(1):215.
[21] 蒋立,李丹丹,杨敏,等.补阳还五汤治疗中风的系统评价再评价[J].中国实验方剂学杂志,2016,22(16):199-204.
[22] 张方圆,沈傲梅,曾宪涛,等.系统评价方法学质量评价工具AMSTAR2解读[J].中国循证心血管医学杂志,2018, 10(1):14-18.
[23] 张伟,孙建华,裴丽霞,等.中医药治疗肠易激综合征的系统评价/Meta分析的再评价[J].世界华人消化杂志,2014,22(12):1747-1755. |
|
|
|